Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.21(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1652
-0.0031(-0.26%)
GBP/USD
1.2546
+0.0013(+0.11%)
Bitcoin GBP
50,246.46
+2,910.45(+6.15%)

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

vTv Therapeutics Inc. (VTVT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

23.63

+0.24

(+1.03%)

At close: 04:00PM EDT

23.02

-0.61

(-2.58%)

After hours:

06:58PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	57.49M
Enterprise value	48.57M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	3.63k
Price/book (mrq)	N/A
Enterprise value/revenue	3.52k
Enterprise value/EBITDA	-1.88

Trading information

Stock price history

Beta (5Y monthly)	0.58
52-week change ³	-24.04%
S&P500 52-week change ³	22.38%
52-week high ³	39.60
52-week low ³	7.38
50-day moving average ³	21.15
200-day moving average ³	17.46

Share statistics

Avg vol (3-month) ³	68.7k
Avg vol (10-day) ³	5.92k
Shares outstanding ⁵	2.43M
Implied shares outstanding ⁶	2.43M
Float ⁸	835.88k
% held by insiders ¹	38.82%
% held by institutions ¹	16.08%
Shares short (15 Apr 2024) ⁴	28.84k
Short ratio (15 Apr 2024) ⁴	1.7
Short % of float (15 Apr 2024) ⁴	3.33%
Short % of shares outstanding (15 Apr 2024) ⁴	1.19%
Shares short (prior month 15 Mar 2024) ⁴	57.18k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	1:40
Last split date ³	21 Nov 2023

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-72.03%
Return on equity (ttm)	N/A

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-25.41M
Net income avi to common (ttm)	-20.25M
Diluted EPS (ttm)	-9.71
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	9.51M
Total cash per share (mrq)	3.91
Total debt (mrq)	529k
Total debt/equity (mrq)	N/A
Current ratio (mrq)	1.00
Book value per share (mrq)	-11.84

Cash flow statement

Operating cash flow (ttm)	-19.08M
Levered free cash flow (ttm)	2.46M